ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.42
+4.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.63x
- Price / sales
- 0.40x
- Price / cash flow
- 5.71x
Enterprise value
- Enterprise value
- $343.4M
- EV / sales
- 0.75x
- EV / EBITDA
- -72.64x
- EV / EBIT
- -11.78x
- Market cap
- $182.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026